Skip to main content
Medical information Clinical review pending

Genetic Testing

Genetic Mapping for Gynecological Disorders Test

Understand your genetic risk for gynecological conditions with our Genetic Mapping for Gynecological Disorders Test. This test uses SNP Genotyping to identify potential predispositions, aiding in proactive health management.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
3 mL (2 mL minimum) of whole blood collected in a lavender top (EDTA) tube.
Results
Approximately 8 weeks. Confirm with the laboratory before booking.
Preparation
No special preparation is required for the patient. Confirm with the laboratory before booking.
Test priceKSh 39,780

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Genetic Mapping for Gynecological Disorders Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Family history of gynecological disorders
  • ✓Unexplained infertility
  • ✓Abnormal menstrual cycles
  • ✓Unexplained pelvic pain
  • ✓Family planning and genetic risk assessment
  • ✓Recurrent gynecological issues
02

In plain language

What this test helps you understand

Identifies genetic predispositions to gynecological disorders, aiding in risk assessment, early detection, and personalized management strategies.
The Genetic Mapping for Gynecological Disorders Test is an advanced diagnostic procedure designed to help understand genetic predispositions to various gynecological conditions. This test utilizes state-of-the-art SNP Genotyping technology, often through microarray methods, to assess an individual’s risk factors associated with disorders of the reproductive system.

Understanding the genetic factors contributing to gynecological disorders is crucial for early detection and effective management. This test is particularly valuable for individuals with a family history of reproductive issues or those experiencing unexplained gynecological symptoms.

The test detects specific genetic markers linked to disorders of the reproductive system. By analyzing a DNA sample, it identifies variations that may increase the risk of developing certain gynecological conditions.

Consider this test if you have a family history of gynecological disorders, are experiencing symptoms like abnormal menstrual cycles, infertility, or unexplained pelvic pain, or are planning a family and wish to understand potential genetic risks.

Benefits include early identification of genetic predispositions for proactive management, informed decision-making for family planning, and personalized treatment options based on genetic insights. Results are typically available within 8 weeks, and your healthcare provider will assist in interpreting the findings.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is required for the patient. Confirm with the laboratory before booking.
Sample3 mL (2 mL minimum) of whole blood collected in a lavender top (EDTA) tube.
MethodologySNP Genotyping using microarray methods.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test identifies genetic predispositions, not definitive diagnoses. Results should be interpreted in conjunction with clinical findings and family history. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This test looks for specific genetic variations (SNPs) associated with an increased risk of developing certain gynecological disorders.
This test identifies genetic predispositions or risks, but it is not a diagnostic test for a specific condition. Results should be interpreted by a healthcare professional.
Individuals with a family history of gynecological disorders, those experiencing unexplained symptoms, or those planning a family may consider this test.
Results are typically provided within 8 weeks and will be discussed with you by your healthcare provider.
No special preparation, such as fasting, is required for this test.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp